Mustang Bio, Inc.

MBIO

Healthcare|Biotechnology|US

$0.39

+0.00 (+0.15%)

DCF Value

$2.93

Tangible Book / Share

$0.98

Cash / Share

$2.12

Analyst Consensus

Buy7 analysts

Strong Buy

Buy

Hold

Sell

Strong Sell

Dec 23

1 buy · 0 hold · 0 sell

Jan 24

1 buy · 0 hold · 0 sell

Feb 24

1 buy · 0 hold · 0 sell

Mar 24

1 buy · 0 hold · 0 sell

Apr 24

1 buy · 0 hold · 0 sell

May 24

1 buy · 0 hold · 0 sell

Jun 24

3 buy · 0 hold · 0 sell

Jul 24

3 buy · 0 hold · 0 sell

Aug 24

2 buy · 0 hold · 0 sell

Sep 24

2 buy · 0 hold · 0 sell

Oct 24

2 buy · 0 hold · 0 sell

Nov 24

1 buy · 0 hold · 0 sell

Firm	Action	Rating	Date
HC Wainwright & Co.	maintain	Buy	May 16, 2024
HC Wainwright & Co.	maintain	Buy	May 13, 2024
Cantor Fitzgerald	maintain	Overweight	Aug 24, 2023
HC Wainwright & Co.	maintain	Buy	Aug 16, 2023
HC Wainwright & Co.	maintain	Buy	Aug 15, 2023
BTIG	maintain	Buy	Aug 15, 2023
HC Wainwright & Co.	maintain	Buy	Jun 16, 2023
BTIG	maintain	Buy	Jun 16, 2023
HC Wainwright & Co.	maintain	Buy	May 15, 2023
BTIG	maintain	Buy	Nov 16, 2022
B. Riley Securities	maintain	Buy	Jan 24, 2022
BTIG	maintain	Buy	May 18, 2021
B. Riley Securities	maintain	Buy	Oct 2, 2020
B. Riley FBR	maintain	Buy	Oct 2, 2020
Oppenheimer	maintain	Outperform	May 12, 2020
HC Wainwright & Co.	maintain	Buy	Aug 13, 2019
H.C. Wainwright	maintain	Buy	Aug 13, 2019
Cantor Fitzgerald	maintain	Overweight	Jun 21, 2019
Oppenheimer	maintain	Outperform	Dec 21, 2017

Report Date	EPS Actual	EPS Est.	Revenue Actual	Revenue Est.
Nov 6, 2026	$-0.14	$-140.00	—	—
Aug 5, 2026	$-0.16	$-140.00	—	—
May 5, 2026	$-0.14	$-140.00	—	—
Mar 19, 2026	$-0.08	$-5.50	—	—
Nov 7, 2025	$-0.07	—	—	—
Aug 8, 2025	$-0.19	—	—	—
May 14, 2025	$-0.05	—	—	—
Mar 24, 2025	$-37.95	$-5.50	—	—